Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Cyclically Adjusted FCF per Share: ¥0.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600613 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
53 GF Score
Price ¥4.97
GF Value ¥5.42
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted FCF per Share?

Shanghai Shenqi Pharmaceutical Investment Management Co SHSE:600613 +1.43% 53 Cyclically Adjusted FCF per Share is ¥0.16 as of Mar. 2026. GuruFocus rates SHSE:600613 with a GF Score™ of 53/100 and a GF Value™ of ¥5.42 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shanghai Shenqi Pharmaceutical Investment Management Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.057. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Shenqi Pharmaceutical Investment Management Co's average Cyclically Adjusted FCF Growth Rate was 14.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 44.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 50.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Shanghai Shenqi Pharmaceutical Investment Management Co was 65.10% per year. The lowest was -26.30% per year. And the median was 0.00% per year.

As of today (2026-07-20), Shanghai Shenqi Pharmaceutical Investment Management Co's current stock price is ¥4.97. Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.16. Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted Price-to-FCF of today is 31.06.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanghai Shenqi Pharmaceutical Investment Management Co was 600.00. The lowest was 27.94. And the median was 160.85.


Shanghai Shenqi Pharmaceutical Investment Management Co  (SHSE:600613) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.97/0.16
=31.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shanghai Shenqi Pharmaceutical Investment Management Co was 600.00. The lowest was 27.94. And the median was 160.85.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted FCF per Share Related Terms


Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted FCF per Share Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.09 0.13 0.15

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.17 0.15 0.16

SHSE:600613 vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600613
53GF Score
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Shenqi Pharmaceutical Investment Management Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Shenqi Pharmaceutical Investment Management Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.057/116.3033*116.3033
=0.057

Current CPI (Mar. 2026) = 116.3033.

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.144 101.400 0.165
201609 -0.050 102.400 -0.057
201612 -0.133 102.600 -0.151
201703 -0.156 103.200 -0.176
201706 0.099 103.100 0.112
201709 -0.033 104.100 -0.037
201712 0.018 104.500 0.020
201803 -0.045 105.300 -0.050
201806 0.118 104.900 0.131
201809 0.009 106.600 0.010
201812 -0.022 106.500 -0.024
201903 0.081 107.700 0.087
201906 0.021 107.700 0.023
201909 0.056 109.800 0.059
201912 -0.075 111.200 -0.078
202003 -0.079 112.300 -0.082
202006 0.012 110.400 0.013
202009 -0.013 111.700 -0.014
202012 0.076 111.500 0.079
202103 0.077 112.662 0.079
202106 -0.030 111.769 -0.031
202109 0.030 112.215 0.031
202112 0.107 113.108 0.110
202203 0.097 114.335 0.099
202206 0.084 114.558 0.085
202209 0.255 115.339 0.257
202212 0.087 115.116 0.088
202303 0.033 115.116 0.033
202306 0.204 114.558 0.207
202309 0.040 115.339 0.040
202312 0.086 114.781 0.087
202403 0.068 115.227 0.069
202406 0.159 114.781 0.161
202409 0.088 115.785 0.088
202412 0.012 114.893 0.012
202503 -0.083 115.116 -0.084
202506 0.120 114.907 0.121
202509 0.176 115.471 0.177
202512 -0.081 115.832 -0.081
202603 0.057 116.303 0.057

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.16 mean?
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) has a Cyclically Adjusted FCF per Share of ¥0.16 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors.
Is Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted FCF per Share too high?
Shanghai Shenqi Pharmaceutical Investment Management Co's current Cyclically Adjusted FCF per Share is ¥0.16. Overall, Shanghai Shenqi Pharmaceutical Investment Management Co has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Shanghai Shenqi Pharmaceutical Investment Management Co's Cyclically Adjusted FCF per Share of ¥0.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. Shanghai Shenqi Pharmaceutical Investment Management Co's current Cyclically Adjusted FCF per Share is ¥0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shenqi Pharmaceutical Investment Management Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.42, compared to a current price of ¥4.97 — trading 8.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.16. Shanghai Shenqi Pharmaceutical Investment Management Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613), the current Cyclically Adjusted FCF per Share is ¥0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be undervalued. The current stock price of ¥4.97 is trading 8.3% below its estimated GF Value™ of ¥5.42. GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Fairly Valued.

Key valuation signals for SHSE:600613:

  • Cyclically Adjusted FCF per Share: ¥0.16
  • GF Value™: ¥5.42 vs. price of ¥4.97 (8.3% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Shenqi Pharmaceutical Investment Management Co Business Description

Other Exchanges 900904:China
Address 128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.
53GF Score

Get the complete analysis for SHSE:600613

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.97
Price
¥5.42
GF Value